The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia
- Author
- THÖRN, Ingrid1 ; OLSSON-STRÖMBERG, Ulla2 ; OHISEN, Cecilia1 ; JONSSON, Anna-Maria1 ; KLANGBY, Ulf3 ; SIMONSSON, Bengt2 ; BARBANY, Gisela1
[1] Department of Genetics and Pathology, Uppsala University Hospital, Sweden
[2] Department of Medical Sciences, Uppsala University Hospital, Sweden
[3] Sangtec Molecular Diagnostics, Bromma, Sweden - Source
Haematologica (Roma). 2005, Vol 90, Num 11, pp 1471-1476, 6 p ; ref : 20 ref
- ISSN
- 0390-6078
- Scientific domain
- Hematology
- Publisher
- Haematologica, Pavia
- Publication country
- Italy
- Document type
- Article
- Language
- English
- Author keyword
- BCR-ABL CML MRD PAXgene real-time PCR
- Keyword (fr)
- Chromosome C9 anormal Chromosome G22 anormal Chromosome Ph1 Chronique Gène hybride Hématologie Leucémie myéloïde Maladie résiduelle imperceptible Protein kinase RNA Réaction chaîne polymérase Stabilisation Stabilité Temps réel Translocation chromosomique Gène abl Gène bcr Protéine bcr-abl Aberration chromosomique Biologie moléculaire Chromosome anormal Enzyme Hémopathie maligne Myéloprolifératif syndrome Transferases
- Keyword (en)
- Abnormal chromosome C9 Abnormal chromosome G22 Philadelphia chromosome Chronic Hybrid gene Hematology Chronic myelocytic leukemia Minimal residual disease Protein kinase RNA Polymerase chain reaction Stabilization Stability Real time Chromosome translocation Bcr-abl protein Chromosomal aberration Molecular biology Abnormal chromosome Enzyme Malignant hemopathy Myeloproliferative syndrome Transferases
- Keyword (es)
- Cromosoma C9 anormal Cromosoma G22 anormal Cromosoma Ph1 Crónico Gen híbrido Hematología Leucemia mieloidea Enfermedad residual imperceptible Protein kinase RNA Reacción cadena polimerasa Estabilización Estabilidad Tiempo real Translocación cromosómica Aberración cromosómica Biología molecular Cromosoma anormal Enzima Hemopatía maligna Mieloproliferativo síndrome Transferases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B23 Medical genetics / 002B23B Chromosome aberrations
- Discipline
- Blood diseases Medical genetics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17262664
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1471\";s:8:\"\u0000*\u0000epage\";s:4:\"1476\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TH\u00d6RN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ingrid\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:23:\"OLSSON-STR\u00d6MBERG, Ulla\";i:1;s:15:\"OHISEN, Cecilia\";i:2;s:19:\"JONSSON, Anna-Maria\";i:3;s:12:\"KLANGBY, Ulf\";i:4;s:16:\"SIMONSSON, Bengt\";i:5;s:15:\"BARBANY, Gisela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1471\";s:8:\"\u0000*\u0000epage\";s:4:\"1476\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TH\u00d6RN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ingrid\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:23:\"OLSSON-STR\u00d6MBERG, Ulla\";i:1;s:15:\"OHISEN, Cecilia\";i:2;s:19:\"JONSSON, Anna-Maria\";i:3;s:12:\"KLANGBY, Ulf\";i:4;s:16:\"SIMONSSON, Bengt\";i:5;s:15:\"BARBANY, Gisela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1471\";s:8:\"\u0000*\u0000epage\";s:4:\"1476\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TH\u00d6RN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ingrid\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:23:\"OLSSON-STR\u00d6MBERG, Ulla\";i:1;s:15:\"OHISEN, Cecilia\";i:2;s:19:\"JONSSON, Anna-Maria\";i:3;s:12:\"KLANGBY, Ulf\";i:4;s:16:\"SIMONSSON, Bengt\";i:5;s:15:\"BARBANY, Gisela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1471\";s:8:\"\u0000*\u0000epage\";s:4:\"1476\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TH\u00d6RN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ingrid\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:23:\"OLSSON-STR\u00d6MBERG, Ulla\";i:1;s:15:\"OHISEN, Cecilia\";i:2;s:19:\"JONSSON, Anna-Maria\";i:3;s:12:\"KLANGBY, Ulf\";i:4;s:16:\"SIMONSSON, Bengt\";i:5;s:15:\"BARBANY, Gisela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Haematologica (Roma)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Haematologica (Roma)\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"90\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"1471\";s:8:\"\u0000*\u0000epage\";s:4:\"1476\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0390-6078\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"TH\u00d6RN\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Ingrid\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:23:\"OLSSON-STR\u00d6MBERG, Ulla\";i:1;s:15:\"OHISEN, Cecilia\";i:2;s:19:\"JONSSON, Anna-Maria\";i:3;s:12:\"KLANGBY, Ulf\";i:4;s:16:\"SIMONSSON, Bengt\";i:5;s:15:\"BARBANY, Gisela\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:98:\"The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Pavia\";s:6:\"\u0000*\u0000pub\";s:13:\"Haematologica\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
